Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17632 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023. Verfasst von Colin J Crooks und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal and Liver Theme, Nottingham Biomedical Research Centre (BRC), Queen's Medical Centre, School of Medicine, National Institute for Hea…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Anemia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
A faecal immunochemical tests (FIT) cut‐off of ≥10 μg Hb/g faeces is now recommended in the UK as a gateway to urgent (suspected cancer) investigation for colorectal cancer (CRC), based on an expected CRC risk threshold of 3%.
Aims
To quantify the risk of CRC at FIT cut‐offs by age, haemoglobin and platelet strata.
Methods
A cohort study of a symptomatic CRC pathway based on primary care FIT tests in Nottingham, UK (November 2017–2021) with 1‐year follow‐up. Heat maps showed the cumulative 1‐year CRC risk using Kaplan–Meier estimates.
Results
In total, 514 (1.5%) CRCs were diagnosed following 33,694 index FIT requests. Individuals with a FIT ≥ 10 μg Hb/g faeces had a >3% risk of CRC, except patients under the age of 40 years (CRC risk 1.45% [95% CI: 0.03%–2.86%]). Non‐anaemic patients with a FIT < 100 μg Hb/g faeces had a CRC risk of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal and Liver Theme, Nottingham Biomedical Research Centre (BRC), Queen's Medical Centre, School of Medicine, National Institute for Health Research (NIHR), Nottingham University Hospitals NHS Trust, Univer…
- Nottingham Colorectal Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Nottingham Bowel Cancer Screening Hub, School of Medicine, University of Nottingham, Nottingham, UK.
- Nottingham City Clinical Commissioning Group Nottingham UK, School of Medicine, University of Nottingham, Nottingham, UK.
- Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Colin J Crooks, Ayan Banerjea, Joe West, David J Humes
Zitieren
APA
Crooks, C. J., Banerjea, A., Jones, J., Chapman, C., Oliver, S., West, J., & Humes, D. J. (2023). Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17632
Vancouver
Crooks CJ, Banerjea A, Jones J, Chapman C, Oliver S, West J, et al. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17632
BibTeX
@article{Crooks2023,
author = {Crooks, Colin J and Banerjea, Ayan and Jones, James and Chapman, Caroline and Oliver, Simon and West, Joe and Humes, David J},
title = {Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17632}
}
EUVIMED